VTP-600

N/A

Report date: 2025/04/11 16:58:59

Base Information

Drug NameVTP-600
Drug Alias NameChAdOx1-MAGEA3-NYESO vaccineChAdOx1-MAGEA3-NYESOVTP-600
ClassificationVaccines > Application > Therapeutic vaccine
Mechanisms of ActionMelanoma-associated antigen 3 modulatorsCancer/testis antigen 1 modulators
TargetsMelanoma-associated antigen 3Cancer/testis antigen 1
Therapy Area/IndicationsCarcinoma, Non-Small-Cell Lung
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited Kingdom
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator CompaniesLudwig Institute For Cancer ResearchBarinthus Biotherapeutics PLC
China Registration ClassN/A

Develop Information

Active CompaniesLudwig Institute For Cancer ResearchCancer Research UK
Inactive CompaniesBarinthus Biotherapeutics PLC
Active IndicationsCarcinoma, Non-Small-Cell Lung
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A